Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study.
Walsh SLF, Maher TM, Kolb M, Poletti V, Nusser R, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown K, Calandriello L, Corte TJ, Cottin V, Crestani B, Flaherty K, Glaspole I, Grutters J, Inoue Y, Kokosi M, Kondoh Y, Kouranos V, Kreuter M, Johannson K, Judge E, Ley B, Margaritopoulos G, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Ryerson CJ, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts W, Hansell D, Wells A; IPF Project Consortium. Walsh SLF, et al. Among authors: wijsenbeek m. Eur Respir J. 2017 Aug 31;50(2):1700936. doi: 10.1183/13993003.00936-2017. Print 2017 Aug. Eur Respir J. 2017. PMID: 28860269 Free article.
Serum biomarkers in idiopathic pulmonary fibrosis.
van den Blink B, Wijsenbeek MS, Hoogsteden HC. van den Blink B, et al. Pulm Pharmacol Ther. 2010 Dec;23(6):515-20. doi: 10.1016/j.pupt.2010.08.001. Epub 2010 Aug 12. Pulm Pharmacol Ther. 2010. PMID: 20708704 Review.
Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis.
Judson MA, Baughman RP, Costabel U, Drent M, Gibson KF, Raghu G, Shigemitsu H, Barney JB, Culver DA, Hamzeh NY, Wijsenbeek MS, Albera C, Huizar I, Agarwal P, Brodmerkel C, Watt R, Barnathan ES. Judson MA, et al. Among authors: wijsenbeek ms. Eur Respir J. 2014 Nov;44(5):1296-307. doi: 10.1183/09031936.00000914. Epub 2014 Jul 17. Eur Respir J. 2014. PMID: 25034562 Free article. Clinical Trial.
[Idiopathic pulmonary fibrosis: new insights].
Kraan JW, van den Blink B, van den Toorn LM, Bresser P, van Beek FT, Grutters JC, Wijsenbeek MS. Kraan JW, et al. Among authors: wijsenbeek ms. Ned Tijdschr Geneeskd. 2015;159:A8148. Ned Tijdschr Geneeskd. 2015. PMID: 25654681 Review. Dutch.
Challenges in the classification of fibrotic ILD.
Bendstrup E, Maher TM, Manali ED, Wijsenbeek M. Bendstrup E, et al. Among authors: wijsenbeek m. Sarcoidosis Vasc Diffuse Lung Dis. 2015 Aug 3;32 Suppl 1:4-9. Sarcoidosis Vasc Diffuse Lung Dis. 2015. PMID: 26237436 Review.
Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy.
van den Blink B, Dillingh MR, Ginns LC, Morrison LD, Moerland M, Wijsenbeek M, Trehu EG, Bartholmai BJ, Burggraaf J. van den Blink B, et al. Among authors: wijsenbeek m. Eur Respir J. 2016 Mar;47(3):889-97. doi: 10.1183/13993003.00850-2015. Epub 2016 Feb 11. Eur Respir J. 2016. PMID: 26869678 Free article. Clinical Trial.
184 results